{"id":"https://genegraph.clinicalgenome.org/r/367ad743-6999-480a-9c3c-1d7e6b459ea9v1.0","type":"EvidenceStrengthAssertion","dc:description":"SAMHD1 was first reported in relation to autosomal recessive Aicardi-Goutieres Syndrome Type 5 (OMIM: 612952) in 2009 when it was shown to act as a negative regulator of the cell-intrinsic antiviral response  (Rice et al., PMID: 19525956). \n\nThe described autosomal recessive SAMHD1 phenotype is considered to be a form of type 1 interferonopathy, which is defined as a condition in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO:0700260). These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response. Individuals with biallelic variants in SAMHD1 can present with a range of symptoms of variable severity and age of onset, within the context of an autoimmune disease. \n\nTwenty variants (missense, frameshift) that have been reported in 10 probands in 3 publications (PMIDs: 20358604, 20653736, 19525956) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity thought to be to be loss of function. This gene-disease relationship is also supported by experimental evidence (model system studies, PMID: 36949945). One study demonstrated that homozygous mutant zebrafish larvae possess a number of neurological phenotypes, exemplified by variable, but increased expression of several ISGs in the head region, a significant increase in brain cell death, microcephaly and locomotion deficits align with human phenotypes. In summary, there is definitive evidence supporting the relationship between SAMHD1 and autosomal recessive SAMHD1-related type 1 interferonopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date April 29, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/367ad743-6999-480a-9c3c-1d7e6b459ea9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-07-01T16:14:26.454Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-07-01T18:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6bef983-ae48-4882-a55e-a792dc41952c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08c5c0cd-95ad-4062-9ee4-d674770c2ff3","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08c5c0cd-95ad-4062-9ee4-d674770c2ff3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/08c5c0cd-95ad-4062-9ee4-d674770c2ff3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","allele":{"id":"https://genegraph.clinicalgenome.org/r/ddcf3766-5635-43b4-80b9-33cd2447bce3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.602T>A (p.Ile201Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249482"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a6bef983-ae48-4882-a55e-a792dc41952c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","rdfs:label":"Ramesh Case 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/ddcf3766-5635-43b4-80b9-33cd2447bce3"},"detectionMethod":"sequencing of single gene","firstTestingMethod":"PCR","phenotypes":["obo:HP_0030880","obo:HP_0002135","obo:HP_0002510","obo:HP_0011834","obo:HP_0003593","obo:HP_0009710"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/08c5c0cd-95ad-4062-9ee4-d674770c2ff3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/682f8057-5efb-4c4e-8dd9-d5fca9da328d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/226e9126-0658-475c-a1bb-a76063f2c3da","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/226e9126-0658-475c-a1bb-a76063f2c3da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/18aa9f13-c682-49dc-b697-0c60f05218c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.428G>A (p.Arg143His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345521"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/682f8057-5efb-4c4e-8dd9-d5fca9da328d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS126 Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/18aa9f13-c682-49dc-b697-0c60f05218c3"},"detectionMethod":"single gene testing","firstTestingMethod":"PCR","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/226e9126-0658-475c-a1bb-a76063f2c3da_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/382eb054-67bc-47c9-93bb-bfcb79150319_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/262515ea-5ef9-4814-a7a4-ad6b65a10e7e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/262515ea-5ef9-4814-a7a4-ad6b65a10e7e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/32326ee5-407b-489f-a906-b1801bd4ecb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.368A>C (p.His123Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340151"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/616a45f4-b6fe-4100-a53d-f17e62b07bec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/616a45f4-b6fe-4100-a53d-f17e62b07bec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/616a45f4-b6fe-4100-a53d-f17e62b07bec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/204e4137-7204-4ece-8607-2a7057fe6b21","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.760A>G (p.Met254Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340153"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/382eb054-67bc-47c9-93bb-bfcb79150319","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS82 Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/32326ee5-407b-489f-a906-b1801bd4ecb8"},{"id":"https://genegraph.clinicalgenome.org/r/204e4137-7204-4ece-8607-2a7057fe6b21"}],"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/616a45f4-b6fe-4100-a53d-f17e62b07bec_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/262515ea-5ef9-4814-a7a4-ad6b65a10e7e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/15128693-bde8-4945-a6aa-8f80dca67154_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f733c07f-d569-44d3-ad18-3b8697f27bcd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f733c07f-d569-44d3-ad18-3b8697f27bcd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f733c07f-d569-44d3-ad18-3b8697f27bcd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/19601ec9-e391-4dfa-b7f7-2b557de18814","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.434G>A (p.Arg145Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345523"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6d13e242-c8d4-400a-8971-90b9c2c001ea","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d13e242-c8d4-400a-8971-90b9c2c001ea_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6d13e242-c8d4-400a-8971-90b9c2c001ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f6ac06a-7610-46f7-a5eb-eac85acd1e44","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1324C>T (p.Arg442Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345512"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/15128693-bde8-4945-a6aa-8f80dca67154","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS91 Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/19601ec9-e391-4dfa-b7f7-2b557de18814"},{"id":"https://genegraph.clinicalgenome.org/r/6f6ac06a-7610-46f7-a5eb-eac85acd1e44"}],"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f733c07f-d569-44d3-ad18-3b8697f27bcd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6d13e242-c8d4-400a-8971-90b9c2c001ea_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/d3ff30dd-e485-46db-85b4-596ba0f8d4d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba5c461a-addb-4060-af6d-e82b4aad51f4","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba5c461a-addb-4060-af6d-e82b4aad51f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7d1a494-a6ee-4af7-b904-3702a20ac71b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1153A>G (p.Met385Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345510"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d3ff30dd-e485-46db-85b4-596ba0f8d4d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS109 Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7d1a494-a6ee-4af7-b904-3702a20ac71b"},"detectionMethod":"Affymetrix GeneChip SNP Human Mapping 50,000 array (50K Xba240). We conducted high-density genotyping using established microsatellite markers and novel markers (D20SG1, D20SG2, D20SG5, D20SG6, D20SG7) derived from the UCSC Human Genome Browser sequence (March 2006 freeze). Microsatellite genotyping was done by standard PCR amplification using fluorescent primers and analysis on an ABI 3130.","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains. ","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ba5c461a-addb-4060-af6d-e82b4aad51f4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/2486b7a0-4036-4bd3-aca5-13265c9dd218_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4458d4c8-c91a-4d7e-b037-2981949fb0ad","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4458d4c8-c91a-4d7e-b037-2981949fb0ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4458d4c8-c91a-4d7e-b037-2981949fb0ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2fba358-c412-44ef-bb7d-cfd54bb6a17a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.625G>A (p.Gly209Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340140"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2486b7a0-4036-4bd3-aca5-13265c9dd218","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS76 Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2fba358-c412-44ef-bb7d-cfd54bb6a17a"},"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4458d4c8-c91a-4d7e-b037-2981949fb0ad_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6484f7b8-df11-46cb-8d95-575b2ac0b6b0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e597e224-a777-42ab-8468-0b02f1ed45a0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e597e224-a777-42ab-8468-0b02f1ed45a0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"   ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/e597e224-a777-42ab-8468-0b02f1ed45a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","allele":{"id":"https://genegraph.clinicalgenome.org/r/e9b469dc-992b-4b0b-ae43-61f04a6f13d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.427C>T (p.Arg143Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342741"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/24df8320-20c3-497d-9b08-916f30b0998d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24df8320-20c3-497d-9b08-916f30b0998d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/24df8320-20c3-497d-9b08-916f30b0998d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","allele":{"id":"https://genegraph.clinicalgenome.org/r/ddcf3766-5635-43b4-80b9-33cd2447bce3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6484f7b8-df11-46cb-8d95-575b2ac0b6b0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","rdfs:label":"Ramesh Case 3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ddcf3766-5635-43b4-80b9-33cd2447bce3"},{"id":"https://genegraph.clinicalgenome.org/r/e9b469dc-992b-4b0b-ae43-61f04a6f13d4"}],"detectionMethod":"sequencing of single gene","firstTestingMethod":"PCR","phenotypeFreeText":"developmental delay, microcephaly, cortical visual impairment, periventricular calcification with ventriculomegaly, violaceous discoloration of the fingers and toes, leukocytoclastic vasculitis, progressive loss of neurological function,bilateral basal ganglia\ncalcification, calcification at the white–grey matter junction, low attenuation in the frontal white matter with subsequent extensive loss of white matter, large subarachnoid haemorrhage","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/24df8320-20c3-497d-9b08-916f30b0998d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e597e224-a777-42ab-8468-0b02f1ed45a0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0079871-4054-48d8-8b9a-8fbe8f3515f9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"AGS91","family":{"id":"https://genegraph.clinicalgenome.org/r/e0079871-4054-48d8-8b9a-8fbe8f3515f9","type":"Family","rdfs:label":"AGS91","member":{"id":"https://genegraph.clinicalgenome.org/r/15128693-bde8-4945-a6aa-8f80dca67154"}},"phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/15128693-bde8-4945-a6aa-8f80dca67154"}},{"id":"https://genegraph.clinicalgenome.org/r/bb4f82f3-9965-4f14-a481-029b73932640_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 affected individuals, doesn't meet criteria for AR conditions.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20358604","rdfs:label":"Dale Family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/bb4f82f3-9965-4f14-a481-029b73932640","type":"Family","rdfs:label":"Dale Family","member":{"id":"https://genegraph.clinicalgenome.org/r/077d6276-2f81-4245-a433-5cf648ae938f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20358604","rdfs:label":"Dale Female Sib","allele":[{"id":"https://genegraph.clinicalgenome.org/r/75dad4bb-0287-4b26-9317-b0d1f2aafd4b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.490C>T (p.Arg164Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252975"}},{"id":"https://genegraph.clinicalgenome.org/r/fdc880eb-4560-4ce4-bf76-5a42a89ec17d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.433C>T (p.Arg145Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340142"}}],"phenotypeFreeText":"postnatal microcephaly, mild learning difficulties, intermittent violaceous urticaria-like rash, mouth ulcers, chilblains, arthropathy","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9d095968-0365-4b2a-b589-ef959181477f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20358604","allele":{"id":"https://genegraph.clinicalgenome.org/r/75dad4bb-0287-4b26-9317-b0d1f2aafd4b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/744de4b2-b867-47d8-a335-397cda29ce2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20358604","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdc880eb-4560-4ce4-bf76-5a42a89ec17d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]}},"meetsInclusionCriteria":false,"phenotypeFreeText":"The older female child showed mild intellectual disability with microcephaly. Her brother demonstrated a significant spastic paraparesis with normal intellect and head size. Both children had an unclassified chronic inflammatory skin condition with chilblains, and recurrent mouth ulcers. One child had a chronic progressive deforming arthropathy of the small and large joints,\nwith secondary contractures.","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/077d6276-2f81-4245-a433-5cf648ae938f"}},{"id":"https://genegraph.clinicalgenome.org/r/37f8a0cc-093c-45d4-8ecf-4e0a9d4efd55_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"AGS76","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/37f8a0cc-093c-45d4-8ecf-4e0a9d4efd55","type":"Family","rdfs:label":"AGS76","member":{"id":"https://genegraph.clinicalgenome.org/r/2486b7a0-4036-4bd3-aca5-13265c9dd218"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2486b7a0-4036-4bd3-aca5-13265c9dd218"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/a7efeebb-56a1-47ca-b19f-aa0c2d3ad7f2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"AGS82","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/a7efeebb-56a1-47ca-b19f-aa0c2d3ad7f2","type":"Family","rdfs:label":"AGS82","member":{"id":"https://genegraph.clinicalgenome.org/r/382eb054-67bc-47c9-93bb-bfcb79150319"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/382eb054-67bc-47c9-93bb-bfcb79150319"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/49c8cbce-a5a9-477b-aef8-4f319246a461_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0170a4f-27bc-41ec-9bee-a35a6c4388c2","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0170a4f-27bc-41ec-9bee-a35a6c4388c2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c0170a4f-27bc-41ec-9bee-a35a6c4388c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","allele":{"id":"https://genegraph.clinicalgenome.org/r/59d4ae51-cb3f-4489-85bb-c0f1e30e43a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.445C>T (p.Gln149Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340145"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/49c8cbce-a5a9-477b-aef8-4f319246a461","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956","rdfs:label":"Rice AGS128 Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/59d4ae51-cb3f-4489-85bb-c0f1e30e43a4"},"detectionMethod":"Affymetrix GeneChip SNP Human Mapping 50,000 array (50K Xba240). We conducted high-density genotyping using established microsatellite markers and novel markers (D20SG1, D20SG2, D20SG5, D20SG6, D20SG7) derived from the UCSC Human Genome Browser sequence (March 2006 freeze). Microsatellite genotyping was done by standard PCR amplification using fluorescent primers and analysis on an ABI 3130.","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c0170a4f-27bc-41ec-9bee-a35a6c4388c2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/341f67ac-54fe-4ad3-9716-c66dcbc17e4d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97635241-7f17-409c-a954-d931981f2bd3","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97635241-7f17-409c-a954-d931981f2bd3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e74b87f-9285-4e22-9b14-44c1d207bfce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1503+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345516"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/341f67ac-54fe-4ad3-9716-c66dcbc17e4d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736","rdfs:label":"Ramesh Case 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e74b87f-9285-4e22-9b14-44c1d207bfce"},"detectionMethod":"sequencing of single gene","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"glaucoma, multiple generalized convulsive seizures, intracranial calcification, raised intraocular pressure, cerebral palsy, ulceration of the tips of his fingers, toes, ears, and nose exacerbated by cold weather; contractures; anterior cerebral artery territory infarcts; stenosis of the supra-clinoid internal carotid arteries","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/97635241-7f17-409c-a954-d931981f2bd3_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/077d6276-2f81-4245-a433-5cf648ae938f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/744de4b2-b867-47d8-a335-397cda29ce2c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/744de4b2-b867-47d8-a335-397cda29ce2c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/744de4b2-b867-47d8-a335-397cda29ce2c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9d095968-0365-4b2a-b589-ef959181477f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d095968-0365-4b2a-b589-ef959181477f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9d095968-0365-4b2a-b589-ef959181477f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/077d6276-2f81-4245-a433-5cf648ae938f"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdb550bf-9374-440d-b5cd-29ba7c64c49d_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf3c5efa-9bf4-4fd4-8a8b-a715cb8d8e12","type":"EvidenceLine","dc:description":"Since this is a non-mammalian model, we have downgraded to 1 point.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02aa2e56-32ba-450e-8a01-967ed22b65b3","type":"Finding","dc:description":"In humans, AGS can present with microcephaly, cerebral hemorrhage, and motor dysfunction, among many other phenotypes. In this zebrafish model, microcephaly, cerebral hemorrhages and motor dysfunction were observed in the samhd1 delta23 mutant line.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36949945","rdfs:label":"SAMHD1 Mutant Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Definitive","sequence":8637,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/IdDOORXZ_N0","type":"GeneValidityProposition","disease":"obo:MONDO_0700260","gene":"hgnc:15925","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_fdb550bf-9374-440d-b5cd-29ba7c64c49d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}